These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 16676324)

  • 1. Separation of a BMS drug candidate and acyl glucuronide from seven glucuronide positional isomers in rat plasma via high-performance liquid chromatography with tandem mass spectrometric detection.
    Xue YJ; Simmons NJ; Liu J; Unger SE; Anderson DF; Jenkins RG
    Rapid Commun Mass Spectrom; 2006; 20(11):1776-86. PubMed ID: 16676324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of a prostaglandin D2 antagonist and its acyl glucuronide metabolite in human plasma by high performance liquid chromatography with tandem mass spectrometric detection--a lack of MS/MS selectivity between a glucuronide conjugate and a phase I metabolite.
    Schwartz MS; Desai RB; Bi S; Miller AR; Matuszewski BK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 837(1-2):116-24. PubMed ID: 16716772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-performance liquid chromatography-mass spectroscopy/mass spectroscopy method for simultaneous quantification of total or free fraction of mycophenolic acid and its glucuronide metabolites.
    Figurski MJ; Korecka M; Fields L; Waligórska T; Shaw LM
    Ther Drug Monit; 2009 Dec; 31(6):717-26. PubMed ID: 19809389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization to eliminate the interference of migration isomers for measuring 1-O-beta-acyl glucuronide without extensive chromatographic separation.
    Xue YJ; Akinsanya JB; Raghavan N; Zhang D
    Rapid Commun Mass Spectrom; 2008; 22(2):109-20. PubMed ID: 18059002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 96-well single-pot protein precipitation, liquid chromatography/tandem mass spectrometry (LC/MS/MS) method for the determination of muraglitazar, a novel diabetes drug, in human plasma.
    Xue YJ; Liu J; Pursley J; Unger S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 831(1-2):213-22. PubMed ID: 16388995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous determination of nicotinic acid and its four metabolites in rat plasma using high performance liquid chromatography with tandem mass spectrometric detection (LC/MS/MS).
    Szafarz M; Lomnicka M; Sternak M; Chlopicki S; Szymura-Oleksiak J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Apr; 878(11-12):895-902. PubMed ID: 20223714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 96-well single-pot liquid-liquid extraction, hydrophilic interaction liquid chromatography-mass spectrometry method for the determination of muraglitazar in human plasma.
    Xue YJ; Liu J; Unger S
    J Pharm Biomed Anal; 2006 Jun; 41(3):979-88. PubMed ID: 16533587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid-liquid extraction of strongly protein bound BMS-299897 from human plasma and cerebrospinal fluid, followed by high-performance liquid chromatography/tandem mass spectrometry.
    Xue YJ; Pursley J; Arnold M
    J Pharm Biomed Anal; 2007 Apr; 43(5):1728-36. PubMed ID: 17204392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simplified protein precipitation/mixed-mode cation-exchange solid-phase extraction, followed by high-speed liquid chromatography/mass spectrometry, for the determination of a basic drug in human plasma.
    Xue YJ; Akinsanya JB; Liu J; Unger SE
    Rapid Commun Mass Spectrom; 2006; 20(18):2660-8. PubMed ID: 16912986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of a rapid and sensitive LC-MS/MS method for determination of exemestane and its metabolites, 17β-hydroxyexemestane and 17β-hydroxyexemestane-17-O-β-D-glucuronide: application to human pharmacokinetics study.
    Wang LZ; Goh SH; Wong AL; Thuya WL; Lau JY; Wan SC; Lee SC; Ho PC; Goh BC
    PLoS One; 2015; 10(3):e0118553. PubMed ID: 25793887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative determination of BMS-378806 in human plasma and urine by high-performance liquid chromatography/tandem mass spectrometry.
    Xue YJ; Yan JH; Arnold M; Grasela D; Unger S
    J Sep Sci; 2007 Jun; 30(9):1267-75. PubMed ID: 17623467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of tapentadol and tapentadol-O-glucuronide in human serum samples by UPLC-MS/MS.
    Hillewaert V; Pusecker K; Sips L; Verhaeghe T; de Vries R; Langhans M; Terlinden R; Timmerman P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Feb; 981-982():40-7. PubMed ID: 25600054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous determination of a selective adenosine 2A agonist, BMS-068645, and its acid metabolite in human plasma by liquid chromatography-tandem mass spectrometry--evaluation of the esterase inhibitor, diisopropyl fluorophosphate, in the stabilization of a labile ester-containing drug.
    Zeng J; Onthank D; Crane P; Unger S; Zheng N; Pasas-Farmer S; Arnold M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):77-84. PubMed ID: 17280881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validated liquid chromatography-tandem mass spectrometric method for the quantitative determination of daidzein and its main metabolite daidzein glucuronide in rat plasma.
    Chen X; Qiu F; Zhong D; Duan X; Liu C
    Pharmazie; 2005 May; 60(5):334-8. PubMed ID: 15918580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple 96-well liquid-liquid extraction with a mixture of acetonitrile and methyl t-butyl ether for the determination of a drug in human plasma by high-performance liquid chromatography with tandem mass spectrometry.
    Xue YJ; Pursley J; Arnold ME
    J Pharm Biomed Anal; 2004 Feb; 34(2):369-78. PubMed ID: 15013151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous determination of three glucuronide conjugates of scutellarein in rat plasma by LC-MS/MS for pharmacokinetic study of breviscapine.
    Wang X; Xia H; Liu Y; Qiu F; Di X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Aug; 965():79-84. PubMed ID: 24999248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rapid, accurate and robust UHPLC-MS/MS method for quantitative determination of BMS-927711, a CGRP receptor antagonist, in plasma in support of non-clinical toxicokinetic studies.
    Zheng N; Zeng J; Akinsanya B; Buzescu A; Xia YQ; Ly V; Trouba K; Peng Q; Aubry AF; Arnold ME
    J Pharm Biomed Anal; 2013 Sep; 83():237-48. PubMed ID: 23770636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of resveratrol and its sulfate and glucuronide metabolites in plasma by LC-MS/MS and their pharmacokinetics in dogs.
    Muzzio M; Huang Z; Hu SC; Johnson WD; McCormick DL; Kapetanovic IM
    J Pharm Biomed Anal; 2012 Feb; 59():201-8. PubMed ID: 22079044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High turbulence liquid chromatography online extraction and tandem mass spectrometry for the simultaneous determination of suberoylanilide hydroxamic acid and its two metabolites in human serum.
    Du L; Musson DG; Wang AQ
    Rapid Commun Mass Spectrom; 2005; 19(13):1779-87. PubMed ID: 15945019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming the stability, solubility and extraction challenges in reversed-phase UHPLC-MS/MS bioanalysis of a phosphate drug and its prodrug in blood lysate.
    Yuan L; Basdeo S; Ji QC
    J Pharm Biomed Anal; 2018 Aug; 157():36-43. PubMed ID: 29758468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.